Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Transenterix Inc (TRXC)

Transenterix Inc (TRXC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Asensus Surgical Announces Finalization of Name and Ticker Symbol Change Business Wire - Fri Mar 5, 2021

Asensus Surgical , Inc. (formerly TransEnterix, Inc.) (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided...

TRXC : 4.08 (-10.13%)
ASXC : 0.2600 (-0.38%)
Asensus Surgical, Inc. Schedules Fourth Quarter and Fiscal Year 2020 Financial and Operating Results Conference Call for March 11, 2021 Business Wire - Thu Mar 4, 2021

Asensus Surgical , Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided...

TRXC : 4.08 (-10.13%)
Asensus Surgical Announces FDA Clearance in General Surgery Business Wire - Wed Mar 3, 2021

Asensus Surgical , Inc. (formerly TransEnterix, Inc.) (NYSE American: TRXC) , a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided...

TRXC : 4.08 (-10.13%)
Asensus Surgical to Present at the H.C. Wainwright Virtual Global Life Sciences Conference Business Wire - Mon Mar 1, 2021

Asensus Surgical , Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided...

TRXC : 4.08 (-10.13%)
TransEnterix Announces Name Change to Asensus Surgical and Introduces a New Category of Surgery, Performance-Guided Surgery Business Wire - Tue Feb 23, 2021

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it will...

TRXC : 4.08 (-10.13%)
TransEnterix Announces New Training Center in EU Business Wire - Thu Feb 18, 2021

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company...

TRXC : 4.08 (-10.13%)
Global Cardiovascular Devices Market Now Project to Exceed $71 Billion By 2027 FinancialNewsMedia - Thu Feb 11, 2021

Palm Beach, FL – February 11, 2021 – Cardiovascular devices are the medical devices which are used to diagnosis and treat the heart diseases and other heart-related problems.  These devices play essential...

PAVM : 1.9700 (+5.35%)
BSGM : 1.6300 (+7.95%)
MDT : 79.08 (-0.21%)
BSX : 67.96 (-0.23%)
TRXC : 4.08 (-10.13%)
TransEnterix to Host Virtual Investor Day on February 23, 2021 Business Wire - Wed Feb 10, 2021

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it will...

TRXC : 4.08 (-10.13%)
TransEnterix Announces Closing of $79.6 Million Bought Deal Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares Business Wire - Mon Feb 1, 2021

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the closing...

TRXC : 4.08 (-10.13%)
TransEnterix Increases Previously Announced Bought Deal Offering of Common Stock to $69.25 Million Business Wire - Tue Jan 26, 2021

TransEnterix, Inc. (NYSE American: TRXC) (“TransEnterix” or the “Company”), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive...

TRXC : 4.08 (-10.13%)

Barchart Exclusives

This Outperforming Dividend Aristocrat Could Rally Another 22%, Says Analyst Barchart - Wed Apr 17, 6:30PM CDT
With a track record of 30 years of dividend increases, this industrial stock is also delivering some outsized capital appreciation to shareholders lately. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot